Diiodothyropropionic acid in the management of cardiovascular disease
Conclusion: DITPA appears to be promising in enhancing cardiac output and hemodynamic stability for heart failure patients, with possible synergistic implications when combined with other heart failure medications. However, extensive human trials are needed to establish its role in the management of heart failure and establish its safety profile.
Source: Cardiovascular Endocrinology - Category: Cardiology Tags: Review Source Type: research
More News: Cardiology | Cardiovascular | Endocrinology | Heart | Heart Failure | Hormones | Laboratory Medicine | Thyroid